Iranian Journal of Pediatrics

Published by: Kowsar

Helicobacter pylori Antibiotic Resistance: What is the Future of Treatment?

Mohammad Zamani 1 , * , Vahid Zamani 2 and Javad Shokri-Shirvani 3
Authors Information
1 Student Research Committee, Babol University of Medical Sciences, Babol, IR Iran
2 Vice-Chancellery for Health, Babol University of Medical Sciences, Babol, IR Iran
3 Department of Internal Medicine, Rohani Hospital, Babol University of Medical Sciences, Babol, IR Iran
Article information
  • Iranian Journal of Pediatrics: August 2016, 26 (4); e5333
  • Published Online: June 14, 2016
  • Article Type: Letter
  • Received: January 9, 2016
  • Revised: February 11, 2016
  • Accepted: March 6, 2016
  • DOI: 10.5812/ijp.5333

To Cite: Zamani M, Zamani V, Shokri-Shirvani J. Helicobacter pylori Antibiotic Resistance: What is the Future of Treatment?, Iran J Pediatr. 2016 ; 26(4):e5333. doi: 10.5812/ijp.5333.

Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Maleknejad S, Mojtahedi A, Safaei-Asl A, Taghavi Z, Kazemnejad E. Primary Antibiotic Resistance to Helicobacter pylori Strains Isolated From Children in Northern Iran: A Single Center Study. Iran J Pediatr. 2015; 25(6): 2661[DOI][PubMed]
  • 2. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children. Aliment Pharmacol Ther. 2012; 36(6): 534-41[DOI][PubMed]
  • 3. Seo JH, Jun JS, Yeom JS, Park JS, Youn HS, Ko GH, et al. Changing pattern of antibiotic resistance of Helicobacter pylori in children during 20 years in Jinju, South Korea. Pediatr Int. 2013; 55(3): 332-6[DOI][PubMed]
  • 4. Khademi F, Faghri J, Poursina F, Esfahani BN, Moghim S, Fazeli H, et al. Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran. J Res Med Sci. 2013; 18(12): 1056-60[PubMed]
  • 5. Ogata SK, Godoy AP, da Silva Patricio FR, Kawakami E. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents. J Pediatr Gastroenterol Nutr. 2013; 56(6): 645-8[DOI][PubMed]
  • 6. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012; 61(5): 646-64[DOI][PubMed]
  • 7. Molina-Infante J, Romano M, Fernandez-Bermejo M, Federico A, Gravina AG, Pozzati L, et al. Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance. Gastroenterology. 2013; 145(1): 121-128 e1[DOI][PubMed]
  • 8. Esmaeili-Dooki MR, Shirdel H, Hajiahmadi M. Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin. Iran J Pediatr. 2015; 25(6): 2360[PubMed]
  • 9. Pacifico L, Osborn JF, Bonci E, Romaggioli S, Baldini R, Chiesa C. Probiotics for the treatment of Helicobacter pylori infection in children. World J Gastroenterol. 2014; 20(3): 673-83[DOI][PubMed]
  • 10. Awaad AS, El-Meligy RM, Soliman GA. Natural products in treatment of ulcerative colitis and peptic ulcer. J Saudi Chem Soc. 2013; 17(1): 101-24
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments